Cargando…
Micro Ribonucleic Acid−29a (miR−29a) Antagonist Normalizes Bone Metabolism in Osteogenesis Imperfecta (OI) Mice Model
Osteogenesis imperfecta (OI) is not curative nowadays. This study tried to unriddle the therapeutic potential of micro ribonucleic acid-29a (miR-29a) antagonist in treating OI in a mouse animal model (B6C3Fe a/a-Col1a2oim/J). We showed that the expression levels of miR-29a were higher in bone tissue...
Autores principales: | Ko, Jih-Yang, Wang, Feng-Sheng, Chen, Sung-Hsiung, Kuo, Shu-Jui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953572/ https://www.ncbi.nlm.nih.gov/pubmed/36831000 http://dx.doi.org/10.3390/biomedicines11020465 |
Ejemplares similares
-
Genetic evaluation of suspected osteogenesis imperfecta (OI)
por: Byers, Peter H., et al.
Publicado: (2006) -
Evaluation of Stomatognathic Problems in Children with Osteogenesis Imperfecta (Osteogenesis Imperfecta − OI) − Preliminary Study
por: Smoląg, Danuta, et al.
Publicado: (2017) -
Living with OI = Osteogenesis imperfecta = brittle bone disease
por: Wallentin, Ute
Publicado: (2010) -
A rare case of osteogenesis imperfecta (OI): clinical image
por: Dhage, Prasad Pramod, et al.
Publicado: (2022) -
29 Juvenile idiopathic arthritis and osteogenesis imperfecta: an exceptional association
por: Emna, Hannech, et al.
Publicado: (2022)